These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
103 related items for PubMed ID: 12749886
1. Binding mode of 6ECDCA, a potent bile acid agonist of the farnesoid X receptor (FXR). Costantino G, Macchiarulo A, Entrena-Guadix A, Camaioni E, Pellicciari R. Bioorg Med Chem Lett; 2003 Jun 02; 13(11):1865-8. PubMed ID: 12749886 [Abstract] [Full Text] [Related]
2. Bile acid derivatives as ligands of the farnesoid X receptor. Synthesis, evaluation, and structure-activity relationship of a series of body and side chain modified analogues of chenodeoxycholic acid. Pellicciari R, Costantino G, Camaioni E, Sadeghpour BM, Entrena A, Willson TM, Fiorucci S, Clerici C, Gioiello A. J Med Chem; 2004 Aug 26; 47(18):4559-69. PubMed ID: 15317466 [Abstract] [Full Text] [Related]
3. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor. Pineda Torra I, Claudel T, Duval C, Kosykh V, Fruchart JC, Staels B. Mol Endocrinol; 2003 Feb 26; 17(2):259-72. PubMed ID: 12554753 [Abstract] [Full Text] [Related]
4. Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasis. Fiorucci S, Clerici C, Antonelli E, Orlandi S, Goodwin B, Sadeghpour BM, Sabatino G, Russo G, Castellani D, Willson TM, Pruzanski M, Pellicciari R, Morelli A. J Pharmacol Exp Ther; 2005 May 26; 313(2):604-12. PubMed ID: 15644430 [Abstract] [Full Text] [Related]
5. 6alpha-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity. Pellicciari R, Fiorucci S, Camaioni E, Clerici C, Costantino G, Maloney PR, Morelli A, Parks DJ, Willson TM. J Med Chem; 2002 Aug 15; 45(17):3569-72. PubMed ID: 12166927 [Abstract] [Full Text] [Related]
6. Bile acids: natural ligands for an orphan nuclear receptor. Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, Kliewer SA, Stimmel JB, Willson TM, Zavacki AM, Moore DD, Lehmann JM. Science; 1999 May 21; 284(5418):1365-8. PubMed ID: 10334993 [Abstract] [Full Text] [Related]
7. The farnesoid X receptor: a novel drug target? Claudel T, Sturm E, Kuipers F, Staels B. Expert Opin Investig Drugs; 2004 Sep 21; 13(9):1135-48. PubMed ID: 15330745 [Abstract] [Full Text] [Related]
8. A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR. Downes M, Verdecia MA, Roecker AJ, Hughes R, Hogenesch JB, Kast-Woelbern HR, Bowman ME, Ferrer JL, Anisfeld AM, Edwards PA, Rosenfeld JM, Alvarez JG, Noel JP, Nicolaou KC, Evans RM. Mol Cell; 2003 Apr 21; 11(4):1079-92. PubMed ID: 12718892 [Abstract] [Full Text] [Related]
9. Farnesoid x receptor ligands inhibit vascular smooth muscle cell inflammation and migration. Li YT, Swales KE, Thomas GJ, Warner TD, Bishop-Bailey D. Arterioscler Thromb Vasc Biol; 2007 Dec 21; 27(12):2606-11. PubMed ID: 18029909 [Abstract] [Full Text] [Related]
10. Phosphorylation of farnesoid X receptor by protein kinase C promotes its transcriptional activity. Gineste R, Sirvent A, Paumelle R, Helleboid S, Aquilina A, Darteil R, Hum DW, Fruchart JC, Staels B. Mol Endocrinol; 2008 Nov 21; 22(11):2433-47. PubMed ID: 18755856 [Abstract] [Full Text] [Related]
11. The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-alpha and -beta genes. Landrier JF, Eloranta JJ, Vavricka SR, Kullak-Ublick GA. Am J Physiol Gastrointest Liver Physiol; 2006 Mar 21; 290(3):G476-85. PubMed ID: 16269519 [Abstract] [Full Text] [Related]
12. Structure-activity relationship of bile acids and bile acid analogs in regard to FXR activation. Fujino T, Une M, Imanaka T, Inoue K, Nishimaki-Mogami T. J Lipid Res; 2004 Jan 21; 45(1):132-8. PubMed ID: 13130122 [Abstract] [Full Text] [Related]
13. Back door modulation of the farnesoid X receptor: design, synthesis, and biological evaluation of a series of side chain modified chenodeoxycholic acid derivatives. Pellicciari R, Gioiello A, Costantino G, Sadeghpour BM, Rizzo G, Meyer U, Parks DJ, Entrena-Guadix A, Fiorucci S. J Med Chem; 2006 Jul 13; 49(14):4208-15. PubMed ID: 16821780 [Abstract] [Full Text] [Related]
14. T0901317 is a dual LXR/FXR agonist. Houck KA, Borchert KM, Hepler CD, Thomas JS, Bramlett KS, Michael LF, Burris TP. Mol Genet Metab; 2004 Jul 13; 83(1-2):184-7. PubMed ID: 15464433 [Abstract] [Full Text] [Related]
15. The nuclear bile acid receptor FXR is activated by PGC-1alpha in a ligand-dependent manner. Kanaya E, Shiraki T, Jingami H. Biochem J; 2004 Sep 15; 382(Pt 3):913-21. PubMed ID: 15202934 [Abstract] [Full Text] [Related]
16. Human organic anion transporting polypeptide 8 promoter is transactivated by the farnesoid X receptor/bile acid receptor. Jung D, Podvinec M, Meyer UA, Mangelsdorf DJ, Fried M, Meier PJ, Kullak-Ublick GA. Gastroenterology; 2002 Jun 15; 122(7):1954-66. PubMed ID: 12055601 [Abstract] [Full Text] [Related]
17. In vitro farnesoid X receptor ligand sensor assay using surface plasmon resonance and based on ligand-induced coactivator association. Fujino T, Sato Y, Une M, Kanayasu-Toyoda T, Yamaguchi T, Shudo K, Inoue K, Nishimaki-Mogami T. J Steroid Biochem Mol Biol; 2003 Dec 15; 87(4-5):247-52. PubMed ID: 14698205 [Abstract] [Full Text] [Related]
18. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Wang H, Chen J, Hollister K, Sowers LC, Forman BM. Mol Cell; 1999 May 15; 3(5):543-53. PubMed ID: 10360171 [Abstract] [Full Text] [Related]
19. Obeticholic acid, a synthetic bile acid agonist of the farnesoid X receptor, attenuates experimental autoimmune encephalomyelitis. Ho PP, Steinman L. Proc Natl Acad Sci U S A; 2016 Feb 09; 113(6):1600-5. PubMed ID: 26811456 [Abstract] [Full Text] [Related]
20. Farnesoid X receptor induces GLUT4 expression through FXR response element in the GLUT4 promoter. Shen H, Zhang Y, Ding H, Wang X, Chen L, Jiang H, Shen X. Cell Physiol Biochem; 2008 Feb 09; 22(1-4):1-14. PubMed ID: 18769028 [Abstract] [Full Text] [Related] Page: [Next] [New Search]